Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4168052
Max Phase: Preclinical
Molecular Formula: C57H96N12O13
Molecular Weight: 1157.47
Molecule Type: Small molecule
Associated Items:
ID: ALA4168052
Max Phase: Preclinical
Molecular Formula: C57H96N12O13
Molecular Weight: 1157.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C57H96N12O13/c1-13-17-39(51(76)68-47(35(11)70)57(82)69-25-16-19-45(69)56(81)67-46(33(8)9)48(59)73)62-54(79)43(28-32(6)7)65-55(80)44(29-37-20-22-38(72)23-21-37)66-50(75)40(18-14-15-24-58)63-53(78)42(27-31(4)5)64-49(74)34(10)60-52(77)41(26-30(2)3)61-36(12)71/h20-23,30-35,39-47,70,72H,13-19,24-29,58H2,1-12H3,(H2,59,73)(H,60,77)(H,61,71)(H,62,79)(H,63,78)(H,64,74)(H,65,80)(H,66,75)(H,67,81)(H,68,76)/t34-,35+,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1
Standard InChI Key: BOOBOONHYXTLJF-IDKRDLHQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1157.47 | Molecular Weight (Monoisotopic): 1156.7220 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):